EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Highly Biocompatible Lamellar Liquid Crystals Based on Hempseed or Flaxseed Oil with Incorporated Betamethasone Dipropionate: A Bioinspired Multi-Target Dermal Drug Delivery System for Atopic Dermatitis Treatment

Mercedes Vitek iD, Žiga Medoš iD, Zoran Lavrič iD, Matjaž Jeras iD, Odon Planinšek iD, Alenka Zvonar Pobirk iD, Mirjam Gosenca Matjaž iD

International Journal of Nanomedicine · 2024

DOI: 10.2147/ijn.s488684 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Mercedes Vitek und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Betamethasone, Dermatitis, Atopic, Liquid Crystals, Administration, Cutaneous. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Atopic dermatitis (AD) is the most common chronic inflammatory skin disease that severely impairs patient's life quality and represents significant therapeutic challenge due to its pathophysiology arising from skin barrier dysfunction. Topical corticosteroids, the mainstay treatment for mild to moderate AD, are usually formulated into conventional dosage forms that are impeded by low drug permeation, resulting in high doses with consequent adverse effects, and also lack properties that would strengthen the skin barrier. Herein, we aimed to develop biomimetic lamellar lyotropic liquid crystals (LLCs), offering a novel alternative to conventional AD treatment.

Methods

In screening studies, pseudoternary phase diagrams alongside polarized light microscopy (PLM) and viscosity measurements were utilized. Next, the selected LCCs underwent comprehensive characterization via PLM, small-angle X-ray scattering, differential scanning calorimetry, and rheological analysis. Lastly, their performance was evaluated and compared with the commercially available reference medicine in chemical stability study, in vitro permeation testing, in vitro safety assessment using cell proliferation assay, inverted light microscopy, and Raman mapping of keratinocytes, besides gap closure assay performed by live-cell imaging.

Results

Formulation (L/T)Ho30, containing the highest amount of lecithin/Tween 80 mixture (21%) and hempseed oil (28%), demonstrated lamellar microstructure with high skin hydration potential and favourable rheological features for skin administration. Moreover, in comparison with the reference medicine, it stood out by providing suitable chemical BD (betamethasone dipropionate) stability, improved 3-fold BD permeation, and excellent biocompatibility with over 85% cell proliferation at all tested concentrations, ensuring keratinocytes' integrity, as well as promoting skin healing with gap closure observed after 36 hours.

Conclusion

Unique multi-target drug delivery strategy depicted in newly developed bioinspired lamellar LCCs structurally resembling stratum corneum intercellular lipids, with incorporated BD drug, and composed of multifunctional components that synergistically strengthen skin barrier, was presented here and shows a promising approach for improved AD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BetamethasoneDermatitis, AtopicLiquid CrystalsAdministration, CutaneousHumansDrug Delivery SystemsSkin AbsorptionSkinCannabisKeratinocytesBiocompatible Materials

Stichwörter der Autor:innen

Raman microspectroscopybiomimeticgap closure assaykeratinocytesmicrostructureskin barrier

Substanzen

Betamethasonebetamethasone-17,21-dipropionateBiocompatible Materials

Autor:innen und Institutionen

  • Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
  • Chair of Physical Chemistry, Faculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia.
  • Department of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.

ORCID-Profile: Mercedes Vitek, Žiga Medoš, Zoran Lavrič, Matjaž Jeras, Odon Planinšek, Alenka Zvonar Pobirk, Mirjam Gosenca Matjaž

Zitieren

APA

Vitek, M., Medoš, Ž., Lavrič, Z., Jeras, M., Planinšek, O., Zvonar Pobirk, A., & Gosenca Matjaž, M. (2024). Highly Biocompatible Lamellar Liquid Crystals Based on Hempseed or Flaxseed Oil with Incorporated Betamethasone Dipropionate: A Bioinspired Multi-Target Dermal Drug Delivery System for Atopic Dermatitis Treatment. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s488684

Vancouver

Vitek M, Medoš Ž, Lavrič Z, Jeras M, Planinšek O, Zvonar Pobirk A, et al. Highly Biocompatible Lamellar Liquid Crystals Based on Hempseed or Flaxseed Oil with Incorporated Betamethasone Dipropionate: A Bioinspired Multi-Target Dermal Drug Delivery System for Atopic Dermatitis Treatment. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s488684

BibTeX
@article{Vitek2024,
  author = {Vitek, Mercedes and Medoš, Žiga and Lavrič, Zoran and Jeras, Matjaž and Planinšek, Odon and Zvonar Pobirk, Alenka and Gosenca Matjaž, Mirjam},
  title = {Highly Biocompatible Lamellar Liquid Crystals Based on Hempseed or Flaxseed Oil with Incorporated Betamethasone Dipropionate: A Bioinspired Multi-Target Dermal Drug Delivery System for Atopic Dermatitis Treatment},
  journal = {International Journal of Nanomedicine},
  year = {2024},
  doi = {10.2147/ijn.s488684}
}
Kostenlos starten →